By combining and digging into the resources of TCGA, GTEx databases, we obtained the expression levels of NCAPG2 under a pan-cancer perspective, indicating that NCAPG2 was statistically over-expressed in 22 common malignancies (Figure 1A), including GBM, CESC, LUAD and others. The gene discussed is NCAPG2; the disease is cancer.